Previous close | 287.53 |
Open | 281.18 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 265.05 - 281.18 |
52-week range | 176.80 - 411.53 |
Volume | |
Avg. volume | 944 |
Market cap | 208.1M |
Beta (5Y monthly) | 1.64 |
PE ratio (TTM) | 0.30 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
McKesson's (MCK) fourth-quarter fiscal 2024 results showcase growth in the U.S. Pharmaceutical while lower COVID-related sales hurt the Medical Surgical Solutions segment.
Nevro's (NVRO) first-quarter earnings and revenues surpass their respective Zacks Consensus Estimate. The company incurs a loss in the operating level.
Inspire Medical's (INSP) both geographic segments witness strong revenue growth in the first quarter.